SV Life Sciences Fund VI, L.P.
6 additional principals, 3 additional placement agents
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- -22%reported GAV
Reported gross assets fell from $260M to $201M between the Form ADV filings of 28 Mar 2024 and 31 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Amounts, each with its basis
- Vintage
- 2015basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $400Mwhat may be sold, not what was raised; file 021-240550, sworn by the adviser or filed under this vehicle
- Form D sold
- $274Mas of the filing of May 26, 2016, 24 investors
- First sale
- May 28, 2015
- Reported GAV
- $201Mon the Form ADV filed Mar 31, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 37
- Reported on ADV
- Mar 30, 2016 to Mar 31, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Lifecycle
Harvest
Lifecycle
The fund's own reporting through time
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 30, 2016 | Venture Capital Fund | $209M | 22 | $1.5M | 1% | yes | |
| Mar 30, 2017 | Venture Capital Fund | $332M | 32 | $1.5M | 1% | yes | |
| Apr 10, 2017 | Venture Capital Fund | $332M | 32 | $1.5M | 1% | yes | |
| Jun 30, 2017 | Venture Capital Fund | $374M | 32 | $1.5M | 1% | yes | |
| Mar 29, 2018 | Venture Capital Fund | $410M | 36 | $1.5M | 1% | yes | |
| Mar 29, 2019 | Venture Capital Fund | $472M | 36 | $1.5M | 1% | yes | |
| May 29, 2019 | Venture Capital Fund | $472M | 36 | $1.5M | 1% | yes | |
| Mar 30, 2020 | Venture Capital Fund | $514M | 36 | $1.5M | 1% | yes | |
| Mar 31, 2021 | Venture Capital Fund | $677M | 36 | $1.5M | 1% | yes | |
| Apr 29, 2021 | Venture Capital Fund | $677M | 36 | $1.5M | 1% | yes | |
| Mar 31, 2022 | Venture Capital Fund | $498M | 36 | $1.5M | 1% | yes | |
| Mar 30, 2023 | Venture Capital Fund | $366M | 36 | $1.5M | 1% | yes | |
| Mar 28, 2024 | Venture Capital Fund | $260M | 36 | $1.5M | 1% | yes | |
| Mar 31, 2026 | Venture Capital Fund | $201M | 37 | $1.5M | 1% |
Principals and agents
- Paul Laviolette Executive Officer
- SV Life Sciences Fund VI (GP), L.P. Executive Officer
- Kate Bingham Executive Officer
- Crito Capital LLC placement agent
Service providers
- AuditorRSM · BOSTON, Massachusetts, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- AdministratorJuniper Square · SAN FRANCISCO, California, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- CustodianBank of America · CHARLOTTE, North Carolina, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.| Allocator | Type | Amount | Date | Source |
|---|---|---|---|---|
| Inasmuch Foundation | FOUNDATION | $780,195 fair value on the foundation's return | reported as of Dec 31, 2024 | Fact IRS Form 990 / 990-PF e-file returns |
Investments attributed to this vehicle
Timeline
- Mar 31, 2026Administrator changed: Juniper Square replaced Apex Group, first reported on the Form ADV filed March 31, 2026 (previous filing March 31, 2025)Administrator changed Fact Form ADV
- Mar 30, 2017Placement Agent changed: Crito Capital LLC replaced INVESTOR'S RESEARCH SECURITIES CORPORATION, first reported on the Form ADV filed March 30, 2017 (previous filing March 30, 2016)Placement agent changed Fact Form ADV
- May 26, 2016SV Life Sciences Fund VI, L.P. filed Form D/A: $273,500,000 sold of $400,000,000, Venture Capital FundForm D filed Fact Form D
- Mar 30, 2016SV Life Sciences Fund VI, L.P. first reported on Form ADV by SV Life Sciences Advisers, LLC (Venture Capital Fund), GAV $208,612,651Fund first reported on Form ADV Fact Form ADV
- May 26, 2015SV Life Sciences Fund VI, L.P. filed Form D: no sales yet of $400,000,000, Venture Capital FundForm D filed Fact Form D
Evidence
Every observation on this vehicle
- Entity type: Limited Partnership May 26, 2016 Fact Form D
- Entity type: Limited Partnership May 26, 2015 Fact Form D
- Form D fund type: Venture Capital Fund May 26, 2016 Fact Form D
- Form D fund type: Venture Capital Fund May 26, 2015 Fact Form D
- Form D industry group: Pooled Investment Fund May 26, 2016 Fact Form D
- Form D industry group: Pooled Investment Fund May 26, 2015 Fact Form D
- Amendment: true May 26, 2016 Fact Form D
- Amendment: false May 26, 2015 Fact Form D
- Revenue range (Form D): Not Applicable May 26, 2016 Fact Form D
- Revenue range (Form D): Not Applicable May 26, 2015 Fact Form D
- Incorporated: withinFiveYears May 26, 2016 Fact Form D
- Incorporated: withinFiveYears May 26, 2015 Fact Form D
- Jurisdiction: Delaware May 26, 2016 Fact Form D
- Jurisdiction: Delaware May 26, 2015 Fact Form D
- Amount sold (Form D): $274M May 26, 2016 Fact Form D
- Amount sold (Form D): $0 May 26, 2015 Fact Form D
- Offering amount (Form D): $400M May 26, 2016 Fact Form D
- Offering amount (Form D): $400M May 26, 2015 Fact Form D
- Exemptions: 06b, 3C, 3C.7 May 26, 2016 Fact Form D
- Exemptions: 06b, 3C, 3C.7 May 26, 2015 Fact Form D
- First sale: 2015-05-28 May 26, 2016 Fact Form D
- Investors (Form D): 24 May 26, 2016 Fact Form D
- Investors (Form D): 0 May 26, 2015 Fact Form D
- Minimum investment (Form D): 0 May 26, 2016 Fact Form D
- Minimum investment (Form D): 0 May 26, 2015 Fact Form D
- Securities offered: pooled May 26, 2016 Fact Form D
- Securities offered: pooled May 26, 2015 Fact Form D
- Office address: May 26, 2016 Fact Form D
- Office address: May 26, 2015 Fact Form D
- Year of incorporation: 2015 May 26, 2016 Fact Form D
- Year of incorporation: 2015 May 26, 2015 Fact Form D
Relationships across DFX
on 2 other DFX graphs
SV Life Sciences Fund VI, L.P. is the same institution as 2 records in Allocators and RIA and Wealth.
DFX found 2 relationships across 2 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Record history
- Form D filed2016-05-26source on record
- Fund first reported on ADV2016-03-30source on record
- Form D filed2015-05-26source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.